An interventional study of Hospital-based pulmonary rehabilitation and Home-based pulmonary rehabilitation in Emphysema, Bronchoscopic Lung Volume Reduction and Hospital-based Pulmonary Rehabilitation, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-03-08.
Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment
The recent years, the use of bronchoscopic lung volume reduction in emphysema patients instead of surgical operations has become widespread. Before this procedure, the implementation of Pulmonary Rehabilitation became a necessity. The inadequacy of the number of Pulmonary Rehabilitation Centers in our country and in our city and the increasing number of mentioned operations have increased the need for different exercise program applications. Prior to valve and coil applications in our study, changes in clinical conditions of patients will be examined if Pulmonary Rehabilitation is performed at home or in a hospital.
The records of emphysema patients referred to the Pulmonary Rehabilitation Unit for prophylactic pulmonary rehabilitation prior to bronchoscopic lung volume reduction will be recorded prospectively. Two parallel groups will be formed from patients with hospital-based pulmonary rehabilitation (Group 1) and those with home-based pulmonary rehabilitation (Group 2). The patient will receive an 8-week Pulmonary Rehabilitation Exercise Program and will be reevaluated after 8 weeks. The differences in the parameters of initial and rehabilitation end-tracing and the differences between the groups will be examined.
339 studies on the registry are indexed under Emphysema; 59 are open to participants now.
This study's enrollment of 66 is above the median of 48 across 208 interventional studies indexed under Emphysema.
Browse Emphysema studies →Istanbul Medipol University Hospital is the lead sponsor of 365 studies on the registry; 59 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-Possible orthopedic, cardiovascular or psychological disturbance that may prevent exercising.
The patient will receive an 8-week supervised Pulmonary Rehabilitation Exercise Program at hospital
Other: Hospital-based pulmonary rehabilitation
The patient will receive an 8-week Pulmonary Rehabilitation Exercise Program at home
Other: Home-based pulmonary rehabilitation
The patient will receive an 8-week Pulmonary Rehabilitation Exercise Program including breathing exercises, treadmill walking, cycle ergometer, arm ergometer training and strengthening trainning with free weights at hospital.
The patient will receive an 8-week Pulmonary Rehabilitation Exercise Program including breathing exercises, free-walking, and strengthening training with free weights at home
Change from baseline distance covered in six-minute walk test at 8 weeks
Time frame: 8 weeks
Change from baseline modified Medical Council Dyspnea score at 8 weeks
The scale will rate the sensation of dyspnea as the person perceives it.The severity of dyspnea is rated on a scale of 0 to 4."0 point" means no dyspnea perception and "4point" means severe dyspnea perception.
Time frame: 8 weeks
Change from baseline Chronic Obstructive Airway Disease assesment test(CAT) score at 8 weeks
The COPD Assessment Test (CAT) is a questionnaire for people with COPD. It is designed to measure the impact of COPD on a person's life, and how this changes over time. Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
Time frame: 8 weeks
Change from baseline Forced Expiratory Volume in 1 second (FEV1) at 8 weeks
Time frame: 8 weeks
Plan to share: Undecided
Ran from May 2018 to primary completion in Nov 2018, 5 months.
Of 39 non-industry interventional studies with no phase under Emphysema, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 59. This study's 5 months is below that.
Counting every sponsor, half of 61 studies reached it within 37 months; a quarter within 25 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medipol University Hospital →